{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:42:54Z","timestamp":1790476974354,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,7,6]]},"DOI":"10.1038\/onc.2017.14","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T13:22:40Z","timestamp":1488806560000},"page":"3878-3889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1\u03b1 translation"],"prefix":"10.1038","volume":"36","author":[{"given":"C","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"BFonc201714_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. Ca-Cancer J Clin 2016; 66: 7\u201330.","journal-title":"Ca-Cancer J Clin"},{"key":"BFonc201714_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ccm.2012.07.001","volume":"33","author":"RW Field","year":"2012","unstructured":"Field RW, Withers BL . Occupational and environmental causes of lung cancer. Clin Chest Med 2012; 33: 681\u2013703.","journal-title":"Clin Chest Med"},{"key":"BFonc201714_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mrfmmm.2003.08.021","volume":"533","author":"KS Kasprzak","year":"2003","unstructured":"Kasprzak KS, Sunderman Jr FW, Salnikow K . Nickel carcinogenesis. Mutat Res 2003; 533: 67\u201397.","journal-title":"Mutat Res"},{"key":"BFonc201714_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11010-005-8215-2","volume":"279","author":"H Lu","year":"2005","unstructured":"Lu H, Shi X, Costa M, Huang C . Carcinogenic effect of nickel compounds. Mol Cell Biochem 2005; 279: 45\u201367.","journal-title":"Mol Cell Biochem"},{"key":"BFonc201714_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M . Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70: 1469\u20131480.","journal-title":"Mol Pharmacol"},{"key":"BFonc201714_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW . Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1\u201312.","journal-title":"Exp Mol Med"},{"key":"BFonc201714_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/0008-5472.CAN-03-0737","volume":"64","author":"J Li","year":"2004","unstructured":"Li J, Davidson G, Huang Y, Jiang BH, Shi X, Costa M et al. Nickel compounds act through phosphatidylinositol-3-kinase\/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells. Cancer Res 2004; 64: 94\u2013101.","journal-title":"Cancer Res"},{"key":"BFonc201714_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jcp.21590","volume":"218","author":"W Ouyang","year":"2009","unstructured":"Ouyang W, Zhang D, Li J, Verma UN, Costa M, Huang C . Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation. J Cell Physiol 2009; 218: 205\u2013214.","journal-title":"J Cell Physiol"},{"key":"BFonc201714_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-09-0448","volume":"70","author":"D Zhang","year":"2010","unstructured":"Zhang D, Li J, Costa M, Gao J, Huang C . JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90\/Hsp70. Cancer Res 2010; 70: 813\u2013823.","journal-title":"Cancer Res"},{"key":"BFonc201714_CR10","doi-asserted-by":"publisher","first-page":"34361","DOI":"10.1074\/jbc.M112.365882","volume":"287","author":"D Zhang","year":"2012","unstructured":"Zhang D, Li J, Zhang M, Gao G, Zuo Z, Yu Y et al. The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1alpha mRNA stability. J Biol Chem 2012; 287: 34361\u201334371.","journal-title":"J Biol Chem"},{"key":"BFonc201714_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M . Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861\u2013874.","journal-title":"Nat Rev Genet"},{"key":"BFonc201714_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2443.2000.00320.x","volume":"5","author":"N Miyoshi","year":"2000","unstructured":"Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K et al. Identification of an imprinted gene, Meg3\/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 2000; 5: 211\u2013220.","journal-title":"Genes Cells"},{"key":"BFonc201714_CR13","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JME-12-0008","volume":"48","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Zhang X, Klibanski A . MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012; 48: R45\u2013R53.","journal-title":"J Mol Endocrinol"},{"key":"BFonc201714_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ijc.26052","volume":"129","author":"L Benetatos","year":"2011","unstructured":"Benetatos L, Vartholomatos G, Hatzimichael E . MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129: 773\u2013779.","journal-title":"Int J Cancer"},{"key":"BFonc201714_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/tx700198a","volume":"21","author":"K Salnikow","year":"2008","unstructured":"Salnikow K, Zhitkovich A . Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008; 21: 28\u201344.","journal-title":"Chem Res Toxicol"},{"key":"BFonc201714_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/ije\/dyr154","volume":"41","author":"L Hou","year":"2012","unstructured":"Hou L, Zhang X, Wang D, Baccarelli A . Environmental chemical exposures and human epigenetics. Int J Epidemiol 2012; 41: 79\u2013105.","journal-title":"Int J Epidemiol"},{"key":"BFonc201714_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1471-2407-13-461","volume":"13","author":"KH Lu","year":"2013","unstructured":"Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013; 13: 461.","journal-title":"BMC Cancer"},{"key":"BFonc201714_CR18","first-page":"5370","volume":"51","author":"JC Willey","year":"1991","unstructured":"Willey JC, Broussoud A, Sleemi A, Bennett WP, Cerutti P, Harris CC . Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res 1991; 51: 5370\u20135377.","journal-title":"Cancer Res"},{"key":"BFonc201714_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2009.10.009","volume":"1803","author":"D Kressler","year":"2010","unstructured":"Kressler D, Hurt E, Bassler J . Driving ribosome assembly. Biochim Biophys Acta 2010; 1803: 673\u2013683.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc201714_CR20","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1101\/gad.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 2005; 19: 2199\u20132211.","journal-title":"Genes Dev"},{"key":"BFonc201714_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN . Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 2014; 15: 155\u2013162.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc201714_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/onc.2013.8","volume":"33","author":"Y Yu","year":"2014","unstructured":"Yu Y, Zhang D, Huang H, Li J, Zhang M, Wan Y et al. NF-kappaB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1. Oncogene 2014; 33: 996\u20131005.","journal-title":"Oncogene"},{"key":"BFonc201714_CR23","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1158\/0008-5472.CAN-04-4184","volume":"65","author":"J Wang","year":"2005","unstructured":"Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z et al. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. Cancer Res 2005; 65: 6601\u20136611.","journal-title":"Cancer Res"},{"key":"BFonc201714_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pharmtox-011112-140338","volume":"54","author":"AC Newton","year":"2014","unstructured":"Newton AC, Trotman LC . Turning off AKT: PHLPP as a drug target. Annu Rev Pharmacol Toxicol 2014; 54: 537\u2013558.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFonc201714_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.036","volume":"335","author":"P Seshacharyulu","year":"2013","unstructured":"Seshacharyulu P, Pandey P, Datta K, Batra SK . Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett 2013; 335: 9\u201318.","journal-title":"Cancer Lett"},{"key":"BFonc201714_CR26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1080\/15548627.2016.1196313","volume":"12","author":"H Huang","year":"2016","unstructured":"Huang H, Zhu J, Li Y, Zhang L, Gu J, Xie Q et al. Upregulation of SQSTM1\/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells. Autophagy 2016; 12: 1687\u20131703.","journal-title":"Autophagy"},{"key":"BFonc201714_CR27","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/jc.2004-1848","volume":"90","author":"J Zhao","year":"2005","unstructured":"Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A . Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 2005; 90: 2179\u20132186.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFonc201714_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/humu.10237","volume":"22","author":"SK Murphy","year":"2003","unstructured":"Murphy SK, Wylie AA, Coveler KJ, Cotter PD, Papenhausen PR, Sutton VR et al. Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat 2003; 22: 92\u201397.","journal-title":"Hum Mutat"},{"key":"BFonc201714_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","volume":"754","author":"B Jin","year":"2013","unstructured":"Jin B, Robertson KD . DNA methyltransferases, DNA damage repair, and cancer. Adv Exp Med Biol 2013; 754: 3\u201329.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc201714_CR30","doi-asserted-by":"publisher","first-page":"e49462","DOI":"10.1371\/journal.pone.0049462","volume":"7","author":"SL Anwar","year":"2012","unstructured":"Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A et al. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One 2012; 7: e49462.","journal-title":"PLoS One"},{"key":"BFonc201714_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s13277-013-1142-z","volume":"35","author":"M Sun","year":"2014","unstructured":"Sun M, Xia R, Jin F, Xu T, Liu Z, De W et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol 2014; 35: 1065\u20131073.","journal-title":"Tumour Biol"},{"key":"BFonc201714_CR32","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s13277-015-3139-2","volume":"36","author":"DD Yin","year":"2015","unstructured":"Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH, Guo RH . Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol 2015; 36: 4851\u20134859.","journal-title":"Tumour Biol"},{"key":"BFonc201714_CR33","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/jcb.24055","volume":"113","author":"P Wang","year":"2012","unstructured":"Wang P, Ren Z, Sun P . Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem 2012; 113: 1868\u20131874.","journal-title":"J Cell Biochem"},{"key":"BFonc201714_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/15384047.2015.1108496","volume":"17","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yao T, Wang Y, Yu J, Liu Y, Lin Z . Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol Ther 2016; 17: 104\u2013113.","journal-title":"Cancer Biol Ther"},{"key":"BFonc201714_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/c2mb25386k","volume":"9","author":"L Ying","year":"2013","unstructured":"Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst 2013; 9: 407\u2013411.","journal-title":"Mol Biosyst"},{"key":"BFonc201714_CR36","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1159\/000438577","volume":"37","author":"G Luo","year":"2015","unstructured":"Luo G, Wang M, Wu X, Tao D, Xiao X, Wang L et al. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem 2015; 37: 2209\u20132220.","journal-title":"Cell Physiol Biochem"},{"key":"BFonc201714_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/cdd.2008.12","volume":"15","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Johnson RS . Biology of HIF-1alpha. Cell Death Differ 2008; 15: 621\u2013627.","journal-title":"Cell Death Differ"},{"key":"BFonc201714_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/cdd.2008.10","volume":"15","author":"GH Fong","year":"2008","unstructured":"Fong GH, Takeda K . Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ 2008; 15: 635\u2013641.","journal-title":"Cell Death Differ"},{"key":"BFonc201714_CR39","doi-asserted-by":"publisher","first-page":"40337","DOI":"10.1074\/jbc.M403057200","volume":"279","author":"K Salnikow","year":"2004","unstructured":"Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS . Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 2004; 279: 40337\u201340344.","journal-title":"J Biol Chem"},{"key":"BFonc201714_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110892","volume":"441","author":"B Magnuson","year":"2012","unstructured":"Magnuson B, Ekim B, Fingar DC . Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012; 441: 1\u201321.","journal-title":"Biochem J"},{"key":"BFonc201714_CR41","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgescu","year":"2010","unstructured":"Georgescu MM . PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer 2010; 1: 1170\u20131177.","journal-title":"Genes Cancer"},{"key":"BFonc201714_CR42","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M . AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131\u2013E136.","journal-title":"Nat Cell Biol"},{"key":"BFonc201714_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/sj.cdd.4401946","volume":"14","author":"K Hettinger","year":"2007","unstructured":"Hettinger K, Vikhanskaya F, Poh MK, Lee MK, de Belle I, Zhang JT et al. c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 2007; 14: 218\u2013229.","journal-title":"Cell Death Differ"},{"key":"BFonc201714_CR44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc1432","volume":"4","author":"SA Belinsky","year":"2004","unstructured":"Belinsky SA . Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004; 4: 707\u2013717.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201714_CR45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/ijo.2015.3285","volume":"48","author":"J Li","year":"2016","unstructured":"Li J, Bian EB, He XJ, Ma CC, Zong G, Wang HL et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int J Oncol 2016; 48: 723\u2013733.","journal-title":"Int J Oncol"},{"key":"BFonc201714_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/ijo.2015.3248","volume":"48","author":"LX Liu","year":"2016","unstructured":"Liu LX, Deng W, Zhou XT, Chen RP, Xiang MQ, Guo YT et al. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells. Int J Oncol 2016; 48: 421\u2013429.","journal-title":"Int J Oncol"},{"key":"BFonc201714_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E . DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247\u2013257.","journal-title":"Cell"},{"key":"BFonc201714_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fonc.2014.00080","volume":"4","author":"D Subramaniam","year":"2014","unstructured":"Subramaniam D, Thombre R, Dhar A, Anant S . DNA methyltransferases: a novel target for prevention and therapy. Front Oncol 2014; 4: 80.","journal-title":"Front Oncol"},{"key":"BFonc201714_CR49","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/neuonc\/nov298","volume":"18","author":"Z Xu","year":"2016","unstructured":"Xu Z, Zeng X, Xu J, Xu D, Li J, Jin H et al. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145\/SOX2\/cyclin D1 axis. Neuro-Oncology 2016; 18: 830\u2013839.","journal-title":"Neuro-Oncology"},{"key":"BFonc201714_CR50","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1158\/1078-0432.CCR-14-2829","volume":"21","author":"H Huang","year":"2015","unstructured":"Huang H, Pan X, Jin H, Li Y, Zhang L, Yang C et al. PHLPP2 downregulation contributes to lung carcinogenesis following B[a]P\/B[a]PDE exposure. Clin Cancer Res 2015; 21: 3783\u20133793.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201714","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc201714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:15:11Z","timestamp":1647879311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":50,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,7,6]]}},"alternative-id":["BFonc201714"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.14","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]},"assertion":[{"value":"8 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}